domingo, 1 de abril de 2018

Genome | Genome Culture: Redefining Health-Risk Testing

Genome | Genome Culture: Redefining Health-Risk Testing



Genome Culture: Redefining Health-Risk Testing

Approval of a direct-to-consumer BRCA test may be a giant step forward for 23andMe, and a giant step back for breast cancer susceptibility testing.
BY LAURA HERCHER 

No hay comentarios:

Publicar un comentario